Gene · 838
Papers1,806
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,806
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caspase-11 contributes to site-1 protease cleavage and SREBP1 activation in the inflammatory response of macrophages. | Front Immunol | 2023 | 36776855 | PubTator, text mining | PubMed |
| From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children. | Int J Mol Sci | 2023 | 36769320 | PubTator, text mining | PubMed |
| Cytoprotective Effects of Human Platelet Lysate during the Xeno-Free Culture of Human Donor Corneas. | Int J Mol Sci | 2023 | 36769200 | PubTator, text mining | PubMed |
| The Dengue virus protease NS2B3 cleaves cyclic GMP-AMP synthase to suppress cGAS activation. | J Biol Chem | 2023 | 36754281 | PubTator, text mining | PubMed |
| Evaluation of Caspase Activation to Assess Innate Immune Cell Death. | J Vis Exp | 2023 | 36744800 | PubTator, text mining | PubMed |
| Relationship between pyroptosis-mediated inflammation and the pathogenesis of prostate disease. | Front Med (Lausanne) | 2023 | 36744134 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast related gene signature in Helicobacter pylori-based subtypes of gastric carcinoma for prognosis and tumor microenvironment estimation in silico analysis. | Front Med (Lausanne) | 2023 | 36744128 | PubTator, text mining | PubMed |
| Cancer-associated pyroptosis: A new license to kill tumor. | Front Immunol | 2023 | 36742298 | PubTator, text mining | PubMed |
| Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response. | J Immunol Res | 2023 | 36741232 | PubTator, text mining | PubMed |
| Oxidative Stress and Pyroptosis in Doxorubicin-Induced Heart Failure and Atrial Fibrillation. | Oxid Med Cell Longev | 2023 | 36733418 | PubTator, text mining | PubMed |
| In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases. | Biomed Res Int | 2023 | 36726838 | PubTator, text mining | PubMed |
| Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. | J Ovarian Res | 2023 | 36707884 | PubTator, text mining | PubMed |
| Pyroptosis in urinary malignancies: a literature review. | Discov Oncol | 2023 | 36702978 | PubTator, text mining | PubMed |
| CaspSites: A Database and Web Application for Experimentally Observed Human Caspase Substrates Using N-Terminomics. | J Proteome Res | 2023 | 36696595 | PubTator, text mining | PubMed |
| Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. | J Immunother Cancer | 2023 | 36693678 | PubTator, text mining | PubMed |
| 3D genome alterations in T cells associated with disease activity of systemic lupus erythematosus. | Ann Rheum Dis | 2023 | 36690410 | PubTator, text mining | PubMed |
| Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. | Cell Prolif | 2023 | 36681858 | PubTator, text mining | PubMed |
| The Effects of Curcumin on Inflammasome: Latest Update. | Molecules | 2023 | 36677800 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Pyroptosis in Melanoma. | Int J Mol Sci | 2023 | 36674798 | PubTator, text mining | PubMed |
| Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles. | Cell Rep Med | 2023 | 36652908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/838/papers?page=15